Human RANKL (Soluble) ELISA Development Kit (ABTS) 900-K142K from Thermo Fisher Scientific

Description

900-K142K consists of: 900-K142 (capture antibody, detection antibody, and protein standard), and AVIDIN-60UL (avidin HRP-conjugate).

Human RANKL (RANK Ligand) ABTS ELISA Development Kit contains the key components required for the quantitative measurement of natural and/or recombinant human RANKL (RANK Ligand) in a sandwich ELISA format. Human RANKL (RANK Ligand) ABTS ELISA Development Kit contains enough material to assay the target cytokine in at least 1,000 ELISA plate wells.

The ABTS ELISA Buffer Kit, sold separately, is recommended to be used in conjunction with this ABTS ELISA Development Kit for optimal performance. This buffer kit contains all the necessary components to assay ten 96-well ELISA plates (included) and contains detailed handling instructions

Product Specs
ItemHuman RANKL (Soluble) ELISA Development Kit (ABTS)
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number900-K142K
ApplicationsSandwich ELISA Kit
Detection TargetRANKL (RANK Ligand)
Quantity10 x 96 Tests
NCBI Full Gene NameTNF superfamily member 11
NCBI Gene AliasesTNLG6B, TRANCE, CD254, sOdf, OPTB2, RANKL, OPGL, hRANKL2, ODF
ReactivityHuman
Detection RangeLot-specific
Assay TimeHands-On Time: 1 hr 45 minTime to Results: 24 hr 30 min
Research AreaCytokine

Add to Compare List

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D(3) and Respond to 24R,25-dihydroxyvitamin D(3) via a Mechanism Dependent on Estrogen Receptor LevelsCancersApril 24, 2024Dennis CD, Dillon JT, Patel PH, Cohen DJ, Halquist MS, Pearcy AC, Boyan BD, Schwartz Z.

(2) Liraglutide-Induced HepatotoxicityBiomedicinesJanuary 22, 2021Maor Y, Ergaz D, Malnick SDH, Melzer E, Neuman MG.

(3) Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in PeriodontitisJournal of immunology (Baltimore, Md. : 1950)November 15, 2016Kanzaki H, Makihira S, Suzuki M, Ishii T, Movila A, Hirschfeld J, Mawardi H, Lin X, Han X, Taubman MA, et al.

(4) Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone lossProceedings of the National Academy of Sciences of the United States of AmericaApril 22, 2014Chen W, Foo SS, Rulli NE, Taylor A, Sheng KC, Herrero LJ, Herring BL, Lidbury BA, Li RW, Walsh NC, et al.

(5) Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenzBMC infectious diseasesFebruary 14, 2012Focà E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A, Izzo I, Bellagamba R, Narciso P, Sighinolfi L, et al.

(6) TGF-β1 as possible link between loss of bone mineral density and chronic inflammationPloS oneNovember 22, 2010Ehnert S, Baur J, Schmitt A, Neumaier M, Lucke M, Dooley S, Vester H, Wildemann B, Stöckle U, Nussler AK.

(7) Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cellsStem CellsMay 1, 2010Tso GH, Law HK, Tu W, Chan GC, Lau YL.

Be the First to Write a Review!

ELISA

Human RANKL (Soluble) ELISA Development Kit (ABTS) from Thermo Fisher Scientific

Description

Thermo Fisher Scientific

Citations (7)

Reviews

Human RANKL (Soluble) ELISA Development Kit (ABTS) from Thermo Fisher Scientific

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map